Ad is loading...
PEQLX
Price
$38.28
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
VVIAX
Price
$69.72
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

PEQLX vs VVIAX

Header iconPEQLX vs VVIAX Comparison
Open Charts PEQLX vs VVIAXBanner chart's image
Putnam Large Cap Value R5
Price$38.28
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$69.72
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
PEQLX vs VVIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PEQLX vs. VVIAX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEQLX is a StrongBuy and VVIAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 184B vs. PEQLX (34.7B). VVIAX pays higher dividends than PEQLX: VVIAX (2.36) vs PEQLX (1.43). PEQLX was incepted earlier than VVIAX: PEQLX (12 years) vs VVIAX (24 years). PEQLX is a more actively managed with annual turnover of: 12.00 vs. VVIAX (10.00). PEQLX has a lower initial minimum investment than VVIAX: PEQLX (0) vs VVIAX (3000). PEQLX annual gain was more profitable for investors over the last year : 28.05 vs. VVIAX (26.09). PEQLX return over 5 years is better than : 57.40 vs. VVIAX (53.09).
PEQLXVVIAXPEQLX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years24 years-
Gain YTD25.19319.672128%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets34.7B184B19%
Annual Yield % from dividends1.432.3661%
Returns for 1 year28.0526.09108%
Returns for 3 years21.7224.7788%
Returns for 5 years57.4053.09108%
Returns for 10 years89.39112.2680%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOLE15.260.19
+1.26%
Dole plc
NCNO40.450.37
+0.92%
nCino
SGHT3.760.03
+0.80%
Sight Sciences
VICI32.370.25
+0.78%
VICI Properties
SABS3.070.01
+0.33%
SAB Biotherapeutics